Ashiq H. Khan

EVP, Chief Commercial Officer

Ashiq H. Khan is EVP Global Head and Chief Commercial Officer of Evotec SE, the German drug discovery and development company, a role he took up on 1 April 2026 with a mandate to build a globally integrated commercial organization aligned with the company's scientific platforms. He previously served as Chief Business Officer at Iktos, the French AI-driven drug design company, and held leadership roles at Proteros and Schrödinger. He brings more than fifteen years of international leadership experience across biotech, CRO and AI-driven platform businesses, managing transcontinental teams and closing more than $7 billion in standalone, integrated and collaboration agreements across the U.S., EU and APAC markets. He holds a PhD in neurobiology from the University of Cologne and business degrees from the Wharton School and INSEAD.